Acting US FDA Chief Sharpless Pledges "Full Speed Ahead" On Agency's Current Agenda

In his first speech to agency staff, Acting Commissioner Norman Sharpless says FDA will continue working on issues including drug pricing and opioids – and he is not approaching the post like a temporary caretaker.